Myriad Genetics (MYGN) Change in Account Payables (2009 - 2026)
Myriad Genetics (MYGN) reported Change in Account Payables of $5.4 million for Q1 2026, up 228.57% quarter-over-quarter from -$4.2 million in Q4 2025.
Myriad Genetics (MYGN) Change in Account Payables (2009 - 2026) Analysis & Trends
Myriad Genetics (MYGN) has 18 years of Change in Account Payables data on file, last reported at $5.4 million in Q1 2026.
- Change in Account Payables for Q1 2026 came in at $5.4 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $4.0 million (up 385.71% YoY), and the FY2025 annual result was -$1.4 million, down 129.79% from the prior year.
- Change in Account Payables advanced to $5.4 million in Q1 2026 per MYGN's latest filing, from -$4.2 million in the prior quarter.
- Over five years, Change in Account Payables peaked at $7.6 million in Q1 2023 and troughed at -$8.5 million in Q3 2023.
- A 5-year average of $93750.0 and a median of -$950000.0 in 2024 frame the typical range for Change in Account Payables.
- The sharpest annual moves came in 2022 and 2023: Change in Account Payables tumbled 1166.67% in 2022, then soared 337.5% in 2023.
- A 5-year view of Change in Account Payables shows it stood at -$2.4 million in 2022, then slumped by 145.83% to -$5.9 million in 2023, then surged by 81.36% to -$1.1 million in 2024, then plunged by 281.82% to -$4.2 million in 2025, then jumped by 228.57% to $5.4 million in 2026.
- Business Quant data shows MYGN's Change in Account Payables at $5.4 million in Q1 2026, -$4.2 million in Q4 2025, and -$800000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | - |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | -41.00 Mn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 11.22 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 15.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 21.88 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | - |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | -12.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | -38.09 Mn |
| 10 | Myriad Genetics | 424.93 Mn | 300.53 Mn | 137.60 Mn | 5.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.40 Mn |
| Mar 31, 2026 | 5.40 Mn |
| Dec 31, 2025 | -4.20 Mn |
| Dec 31, 2025 | -4.20 Mn |
| Sep 30, 2025 | -800,000.00 |
| Sep 30, 2025 | -800,000.00 |
| Jun 30, 2025 | 3.60 Mn |
| Jun 30, 2025 | 3.60 Mn |
| Dec 31, 2024 | -1.10 Mn |
| Dec 31, 2024 | -1.10 Mn |
| Sep 30, 2024 | -3.60 Mn |
| Sep 30, 2024 | -3.60 Mn |
| Jun 30, 2024 | 3.30 Mn |
| Jun 30, 2024 | 3.30 Mn |
| Mar 31, 2024 | 6.10 Mn |
| Mar 31, 2024 | 6.10 Mn |
| Dec 31, 2023 | -5.90 Mn |
| Dec 31, 2023 | -5.90 Mn |
| Sep 30, 2023 | -8.50 Mn |
| Sep 30, 2023 | -8.50 Mn |